Skip to Main Content

Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it paid to a charity were actually kickbacks to Medicare patients used to cover out-of-pockets costs for its medicine used to treat a type of high blood pressure.

This is only the latest instance in which federal authorities have cracked down on such arrangements between drug makers and patient assistance charities.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

    • Hi David,

      Thanks for writing in. And yes, federal authorities have extracted settlements from numerous drug makers over the past year for the same alleged practices. Do a search on our site using the words ‘Medicare,’ ‘kickback’ and ‘foundation,’ and you’ll see what I mean.

      So in that way, Gilead isn’t any different than the others.

      All best
      ed at pharmalot

    • Hi TW,

      Thanks for the note.
      And yes, in the lead sentence, I opted for a quick description.

      The focus of the story was on the alleged practices. Many companies have been tagged by federal authorities for the same thing involving all sorts of drugs for all sorts of maladies.

      Nonetheless, yes, I could have added a line later explaining PAH in a little more detail. There was no attempt to mislead. The alleged violations were serious regardless of the illness involved.

      Hope this helps,
      ed at pharmalot

Comments are closed.